moomoo ID:NaN
Log Out
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > RLAY Relay Therapeutics > Company Executives
RLAY Relay Therapeutics
NamePositionSalaryService DateEducationAgeGenderUpdated
Mr. Sanjiv K. Patel, M.D.Director, President and Chief Executive Officer8.53M----48male04/14/2022
Mr. Brian AdamsChief Legal Officer1.89M----48male04/14/2022
Mr. Thomas CatinazzoChief Financial Officer and Principal Accounting Officer1.84M----45male04/14/2022
Ms. Andy PorterChief Administrative Officer1.75M----47female04/14/2022
Mr. Alexis A. Borisy, A.M.Chairman of the Board429.59K----50male04/14/2022
Dr. Donald A. Bergstrom, M.D.,PhDPresident, Research and Development3.54M----50male04/14/2022
Mr. Mark Murcko,PhDDirector390.34K----62male04/14/2022
Mr. Douglas S. Ingram,Esq.Independent Director398.34K----59male04/14/2022
Dr. Linda A. Hill,PhDIndependent Director394.22K----65female04/14/2022
Dr. Laura Shawver, PhDIndependent Director385.22K----64female04/14/2022
Ms. Jami RubinIndependent Director405.34K----58female04/14/2022
Dr. Sekar Kathiresan, M.D.Independent Director--------male07/27/2022
Company Overview More
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
CEO: Mr. Sanjiv K. Patel, M.D.
Market: NASDAQ
Listing Date: 07/16/2020
Hot List
SymbolLatest price%Chg